Major Depressive Disorder, Single Episode, Unspecified Clinical Trial
Official title:
Attention Bias Modification Treatment for Major Depressive Disorder in Adolescents: A Randomized Controlled Trial
NCT number | NCT02078258 |
Other study ID # | 1 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2012 |
Est. completion date | July 2015 |
Verified date | March 2019 |
Source | Hunan Normal University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this study, we test whether a two-week 8-session neutral attention bias modification (ABM) training and a two-week 4-session positive ABM could reduce depressive symptoms relative to placebo controls in adolescents with major depressive disorder at posttraining and follow-ups during one year.
Status | Completed |
Enrollment | 45 |
Est. completion date | July 2015 |
Est. primary completion date | January 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 11 Years to 19 Years |
Eligibility |
Inclusion Criteria: - Meet the major depression disorder's criteria Exclusion Criteria: - bipolar disorder, schizophrenia or organic mental disorder; - any concurrent psychotherapy; - any concurrent psychotropic medication. |
Country | Name | City | State |
---|---|---|---|
China | Department of Psychology, Hunan Normal University | Changsha | Hunan |
Lead Sponsor | Collaborator |
---|---|
Hunan Normal University |
China,
Yang W, Zhang JX, Ding Z, Xiao L. Attention Bias Modification Treatment for Adolescents With Major Depression: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):208-18.e2. doi: 10.1016/j.jaac.2015.12.005. Epub 2015 Dec 23. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in depressive symptom number | Depressive symptom accounts measured by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children. | baseline, 7-week, 6-month follow-up | |
Primary | Changes in depressive severity | depressive severity measured by the construct interview of the Schedule for Affective Disorders and Schizophrenia for School-Age Children(K-SADS) | baseline, 7-week, 6-month follow-up | |
Secondary | Change of Self-report symptoms | symptoms measured by the Center for Epidemiological Studies Depression Scale (CES-D), State-Trait Anxiety Inventory-Trait(STAI-T),Rumination Response Style(RRS),Suicidal Ideation Questionnaire(SIQ) | baseline, 7-week, 6-, 12-month follow-up | |
Secondary | Diagnostic status of major depressive disorder | Assessed by the diagnostic interview of the Schedule for Affective Disorders and Schizophrenia for School-Age Children | baseline, 7-week, 6-month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01894815 -
Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
|
Phase 3 | |
Completed |
NCT01726387 -
Self-Management for Anxiety, Depression and Somatoform Disorders
|
N/A | |
Completed |
NCT01361815 -
Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)
|
N/A |